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Do genotype-based changes in
serum uric acid really affect blood
pressure?
To the Editor: Parsa et al.1 used Mendelian randomization to
test the causal association between serum uric acid (SUA) and
blood pressure. They found that decreases in SUA concentra-
tion due to a missense single-nucleotide polymorphism in
the GLUT9 gene are directly associated with a lower level of
blood pressure and concluded that SUA is causally associated
with blood pressure. However, in the association analysis of
SUA and blood pressure, only age and gender were adjusted.
We are wondering whether the association between SUA
and blood pressure remains signiﬁcant upon further adjust-
ment for other important covariates. Actually, a previous
study has shown that the relationship between SUA and
blood pressure was attenuated by up to 50% upon further
adjustment for body mass index, waist–hip ratio, or body
fat percent.2 A recent meta-analysis has found a modest but
signiﬁcantly increased relative risk for incident hypertension
in subjects with hyperuricemia, independent of traditional
risk factors for hypertension.3 However, adjusting for
measures of insulin resistance could bias the effect estimates
toward the null.3 In our cross-sectional study including
4387 subjects randomly selected from a general population,
SUA was signiﬁcantly associated with systolic and diastolic
blood pressures adjusting for gender and age, but the
association was no longer signiﬁcant after the further
adjustment of body mass index and waist–hip ratio (Table 1).
If the association between SUA and blood pressure is no
longer signiﬁcant after complete adjustment, then the causal
association might not be proved even with the use of
Mendelian randomization.
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The Authors Reply: We fully appreciate the concern raised
by Zhang et al.1 regarding the unadjusted association between
serum uric acid (SUA) and blood pressure. Indeed, this was
the reason for our performing the Mendelian randomization
(MR) analysis.2 MR is based on the tenet that genotype, which
is randomly assigned during gamete formation and ﬁxed,
cannot be modiﬁed by any of the traditional risk factors
(e.g., obesity and diabetes) that occur after conception and
hence is not confounded by them.3 It is critical for the reader
to be cognizant of this premise and, moreover, recognize that
our analysis looked at the environmentally unconfounded and
unidirectional association between GLUT9 genotype and
blood pressure, as opposed to the easily confoundable asso-
ciation between SUA and blood pressure.2 Indeed, as proof of
concept, we showed in Table 2 of our original article that
SUA was strongly associated with glucose, renal function, and
body mass index (P values of 2.5 108, 1.4 1014, and
1.5 1031, respectively), while, as expected, the GLUT9
genotype was not associated with these factors.2 Conferring
with the premise of MR and the complete lack of association
between GLUT9 genotype and glucose, obesity, dyslipidemia,
and renal function, we suitably did not adjust for them in our
analysis.2 We refer Zhang et al.1 and the interested reader to
a few of many reviews, for further details on how the use of
MR in the appropriate setting can allow for reliable causal
inferences,3,4 as in the case of SUA and blood pressure.
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Table 1 | Association between serum uric acid and blood pressure
Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg)
Serum uric acid (lmol/l) b s.e. P b s.e. P
Model 1 0.038 0.003 o0.0001 0.023 0.002 o0.0001
Model 2 0.026 0.003 o0.0001 0.016 0.002 o0.0001
Model 3 0.011 0.003 0.001 0.010 0.002 o0.0001
Model 4 0.0002 0.003 0.95 0.0005 0.002 0.78
Model 5 0.0014 0.004 0.69 0.0015 0.002 0.43
Model 1 encompasses linear regression analysis of circulating uric acid and blood pressure; model 2, adjusted for age and sex; model 3, as model 2 plus antihypertensive
medication and heart rate; model 4, as model 3 plus body mass index and waist-to-hip ratio; model 5, as model 4 plus triglycerides, total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol, and serum glucose.
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Urinary biomarkers in autosomal
dominant polycystic kidney
disease: is there no prognostic
value?
To the Editor: We read with interest the article by Parikh
et al, in which they showed that levels of neutrophil
gelatinase-associated lipocalin (NGAL) and interleukin (IL)-
18 did not correlate with changes in kidney volume or
estimated glomerular ﬁltration rate (eGFR) during follow-up
in autosomal dominant polycystic kidney disease (ADPKD)
patients relatively early in their disease.1 Therefore, it was
suggested that urinary biomarkers of kidney injury have no
clinical prognostic utility.
Recently, we measured several biomarkers (glomerular,
tubular, and inﬂammatory) in urine samples (stored for 0.7
years at80 1C) of 102 ADPKD patients and found in a cross-
sectional study signiﬁcant associations between several urinary
biomarkers, including NGAL, and measures of ADPKD
severity.2 After having read the publication by Parikh et al,
we investigated the association of these markers with decline
in eGFR (Chronic Kidney Disease Epidemiology Collaboration)
in patients whose follow-up data were available without experi-
mental intervention (N¼ 46, age 40±14 years, 48% male,
baseline eGFR 73±37ml/min per 1.73 m2, eGFR change
during 2.6 years follow-up: 2.6±3.2ml/min per 1.73 m2/year).
We found signiﬁcant inverse associations between baseline
urinary biomarker excretion of albumin, IgG, KIM-1, and
MCP-1 and change in eGFR during follow-up (Table 1).
These associations remained signiﬁcant after adjustment for
age, gender, and baseline eGFR. Similar to Parikh et al, we
found no signiﬁcant association between NGAL and change
in eGFR, neither crude (P¼ 0.07) nor adjusted for age, sex, and
baseline eGFR (P¼ 0.47). Urinary IL-18 was not measured.
Importantly, we have previously shown that frozen storage
decreases the measured concentration of urinary biomarkers,
such as NGAL, and induces more variability, especially after
longer storage.3 The decline or increased variability in marker
concentration that is induced by frozen storage can therefore
reduce the association that, in reality, is present. We have
shown this latter phenomenon for urinary albumin concen-
tration in non-ADPKD subjects.4
Given these ﬁndings, we caution against a too skeptical
view toward the utility of urinary biomarkers to predict
disease progression in ADPKD. Our data indicate that some
of these markers may be useful. More research investigating
their prognostic value in ADPKD is deﬁnitely needed.
1. Parikh CR, Dahl NK, Chapman AB et al. Evaluation of urine biomarkers of
kidney injury in polycystic kidney disease. Kidney Int 2012; 81: 784–790.
2. Meijer E, Boertien WE, Nauta FL et al. Association of urinary biomarkers
with disease severity in patients with autosomal dominant polycystic
kidney disease: a cross-sectional analysis. Am J Kidney Dis 2010; 56:
883–895.
3. Nauta FL, Bakker SJ, Lambers Heerspink H et al. Effect of frozen storage
on urinary concentration of kidney damage markers. Am J Kidney Dis 2012;
59: 586–589.
4. Brinkman JW, de Zeeuw D, Gansevoort RT et al. Prolonged frozen storage
of urine reduces the value of albuminuria for mortality prediction.
Clin Chem 2007; 53: 153–154.
Wendy E. Boertien1, Esther Meijer1 and
Ron T. Gansevoort1
1Department of Nephrology, University Medical Center Groningen, University
of Groningen, Groningen, The Netherlands
Correspondence: Ron T. Gansevoort, Department Nephrology, University
Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB
Groningen, The Netherlands. E-mail: r.t.gansevoort@umcg.nl
Kidney International (2012) 82, 361; doi:10.1038/ki.2012.146
Reappraisal of melamine exposure
and adult calcium urolithiasis
To the Editor: In reference to Lopez and Quereda’s comments
to our recent article and questions about source of low-dose
melamine exposure and change in incidence in urolithiasis
in adults in Taiwan,1,2 since the melamine-tainted formula
incident in China in 2008, melamine has been detected in a
few daily food products such as eggs, wheat gluten, and meats.
Our recent study found that some melamine could migrate
from daily-used melamine-made tableware even at room
Table 1 | Association between slope of eGFR (CKD-EPI) and
log-transformed urinary biomarker excretion
Crude
Adjusted for age,
gender, and baseline
eGFR
Std. B P-value Std. B P-value
Albumin (mg/24 h) 0.542 o0.001 0.474 0.005
IgG (mg/24h) 0.419 0.004 0.310 0.044
KIM-1 (mg/24 h) 0.347 0.018 0.447 0.001
MCP-1 (mg/24 h) 0.483 0.001 0.390 0.006
Abbreviations: CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; eGFR,
estimated glomerular filtration rate; IgG, Imunoglobulin G; KIM-1, kidney injury
molecule 1; MCP-1, monocyte chemotactic protein 1.
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